ALPN
Alpine Immune Sciences Inc
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
70 hedge funds and large institutions have $255M invested in Alpine Immune Sciences Inc in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more funds holding
Funds holding: 58 → 70 (+12)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
70
Holding in Top 10
4
Calls
–
Puts
$1K
Top Buyers
| 1 | +$31.4M | |
| 2 | +$20.9M | |
| 3 | +$14.4M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$9.99M |
| 5 |
CC
Commodore Capital
New York
|
+$9.54M |
Top Sellers
| 1 | -$2.33M | |
| 2 | -$1M | |
| 3 | -$428K | |
| 4 |
Renaissance Technologies
New York
|
-$279K |
| 5 |
Two Sigma Advisers
New York
|
-$238K |